Literature DB >> 15834508

Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan.

Trang-Tiau Wu1,2, Tsui-Wei Tsai3, Chao-Ta Chu3, Zen-Fung Lee4, Chuan-Mao Hung2,3, Ching-Chyuan Su2,5, Shuan-Yow Li3, Mingli Hsieh3,6, Chuan Li7.   

Abstract

Hirschsprung disease (HSCR), or congenital intestinal aganglionosis, is a relatively common disorder characterized by the absence of ganglion cells in the nerve plexuses of the lower digestive tract, resulting in intestinal obstruction in neonates. Mutations in genes of the RET receptor tyrosine kinase and endothelin receptor B (EDNRB) signaling pathways have been shown to be associated in HSCR patients. In this study, we collected genomic DNA samples from 55 HSCR patients in central Taiwan and analyzed the coding regions of the RET and EDNRB genes by PCR amplification and DNA sequencing. In the 55 patients, an A to G transition was detected in two (identical twin brothers). The mutation was at the end of RET exon 19 at codon 1062 (Y1062C), a reported critical site for the signaling pathways. Single nucleotide polymorphisms (SNP) in exons 2, 7, 11, 13, and 15 of RET and exon 4 of EDNRB in the HSCR patients or controls were detected. The differences between patients and controls in allele distribution of the five RET polymorphic sites were statistically significant. The most frequent genotype encompassing exons 2 and 13 SNPs (the polymorphic sites with the highest percentage of heterozygotes) was AA/GG in patients, which was different from the AG/GT in the normal controls. Transmission disequilibrium was observed in exons 2, 7, and 13, indicating nonrandom association of the susceptibility alleles with the disease in the patients. This study represents the first comprehensive genetic analysis of HSCR disease in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834508     DOI: 10.1007/s10038-005-0236-x

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  36 in total

1.  Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease.

Authors:  G Fitze; M Schreiber; E Kuhlisch; H K Schackert; D Roesner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.

Authors:  S Borrego; A Ruiz; M E Saez; O Gimm; X Gao; M López-Alonso; A Hernández; F A Wright; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

3.  RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2.

Authors:  M J Lorenzo; G D Gish; C Houghton; T J Stonehouse; T Pawson; B A Ponder; D P Smith
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

4.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Authors:  M Takahashi; Y Buma; T Iwamoto; Y Inaguma; H Ikeda; H Hiai
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

5.  Adult-onset Hirschsprung's disease.

Authors:  P B Lesser; A M El-Nahas; P Lukl; P Andrews; J G Schuler; H S Filtzer
Journal:  JAMA       Date:  1979 Aug 24-31       Impact factor: 56.272

6.  A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10.

Authors:  M Angrist; E Kauffman; S A Slaugenhaupt; T C Matise; E G Puffenberger; S S Washington; A Lipson; D T Cass; T Reyna; D E Weeks
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Frequency of RET mutations in long- and short-segment Hirschsprung disease.

Authors:  M Seri; L Yin; V Barone; A Bolino; I Celli; R Bocciardi; B Pasini; I Ceccherini; M Lerone; U Kristoffersson; L T Larsson; J M Casasa; D T Cass; M J Abramowicz; J M Vanderwinden; I Kravcenkiene; I Baric; M Silengo; G Martucciello; G Romeo
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

8.  Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.

Authors:  B Doray; R Salomon; J Amiel; A Pelet; R Touraine; M Billaud; T Attié; B Bachy; A Munnich; S Lyonnet
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

9.  Hirschsprung disease in infants and children.

Authors:  G Frost
Journal:  Gastroenterol Nurs       Date:  1992-08       Impact factor: 0.978

10.  A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction.

Authors:  R M Hofstra; O Valdenaire; E Arch; J Osinga; H Kroes; B M Löffler; A Hamosh; C Meijers; C H Buys
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more
  7 in total

1.  RET and EDNRB mutation screening in patients with Hirschsprung disease: Functional studies and its implications for genetic counseling.

Authors:  Titis Widowati; Shamiram Melhem; Suryono Y Patria; Bianca M de Graaf; Richard J Sinke; Martijn Viel; Jos Dijkhuis; Ahmad H Sadewa; Rochadi Purwohardjono; Yati Soenarto; Robert Mw Hofstra; Yunia Sribudiani
Journal:  Eur J Hum Genet       Date:  2015-09-23       Impact factor: 4.246

2.  Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Piyawan Chengkriwate; Sakda Patrapinyokul; Burapat Sangthong; Masahiro Fukuzawa
Journal:  J Hum Genet       Date:  2006-09-29       Impact factor: 3.172

3.  Correlating of GSTM1, GSTT1, and GSTP1 genetic polymorphisms with the risk and expressions in children with isolated Hirschsprung disease.

Authors:  Hong Gao; Rong He; Xiaojing He; Zhibo Zhang; Dajia Wang; Liangying Lv; Weilin Wang; Ying Huang
Journal:  Int J Colorectal Dis       Date:  2010-07-27       Impact factor: 2.571

4.  Correlation between multiple RET mutations and severity of Hirschsprung's disease.

Authors:  Kunihiro Ishii; Takashi Doi; Ken Inoue; Manabu Okawada; Geoffrey J Lane; Atsuyuki Yamataka; Chihiro Akazawa
Journal:  Pediatr Surg Int       Date:  2013-02       Impact factor: 1.827

5.  Comprehensive analysis of RET common and rare variants in a series of Spanish Hirschsprung patients confirms a synergistic effect of both kinds of events.

Authors:  Rocio Núñez-Torres; Raquel M Fernández; Manuel Jesus Acosta; Maria Del Valle Enguix-Riego; Martina Marbá; Juan Carlos de Agustín; Luis Castaño; Guillermo Antiñolo; Salud Borrego
Journal:  BMC Med Genet       Date:  2011-10-13       Impact factor: 2.103

6.  Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.

Authors:  Yu-Jen Lee; Wen-Wei Chang; Chien-Ping Chang; Tsung-Yun Liu; Chun-Yi Chuang; Kun Qian; Y George Zheng; Chuan Li
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

7.  Negative Association Between lncRNA HOTTIP rs3807598 C>G and Hirschsprung Disease.

Authors:  Yi Zheng; Zhenjian Zhuo; Xiaoli Xie; Lifeng Lu; Qiuming He; Wei Zhong
Journal:  Pharmgenomics Pers Med       Date:  2020-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.